Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations-Reference-Cited by-同舟云学术

Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations

Published:2004-05 Issue:5 Volume:10 Page:287-297
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Fraser Graeme A.M.,Walker Irwin I.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference49 articles.

1. Risk factors for cytomegalovirus infection after human marrow transplantation;Meyers;J Infect Dis,1986

2. Acyclovir for prevention of cytomegalovirus and disease after allogeneic marrow transplantation;Meyers;N Engl J Med,1988

3. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation;Wingard;Blood,1988

4. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant;Goodrich;Ann Intern Med,1993

5. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial;Winston;Ann Intern Med,1993

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical risk factors and prognostic model for idiopathic inflammatory demyelinating diseases after haploidentical hematopoietic stem cell transplantation in patients with hematological malignancies;American Journal of Hematology;2021-08-17

2. Transfusion in Transplantation;Transfusion Medicine and Scientific Developments;2017-07-05

3. When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipients?;Bone Marrow Transplantation;2017-06-05

4. Successful treatment of cytomegalovirus pneumonia in a child on maintenance chemotherapy for acute lymphoblastic leukemia without the use of intravenous immunoglobulin;Pediatric Hematology Oncology Journal;2017-03

5. Cytomegalovirus Infection Management in Allogeneic Stem Cell Transplant Recipients: a National Survey in Spain;Journal of Clinical Microbiology;2015-06-10